Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Speculation on Next Tuesdays Exciting News
View:
Post by toade1313 on Jul 30, 2024 7:15am

Speculation on Next Tuesdays Exciting News

I too received the email and am so happy that it is real and from the company. Here are my thoughts even though they are from someone with only a 184 reputation. 

1. If it's as exciting as forcast, it can only be that they have Filed for the BTD!!!

2. If by some miracle they had actually gotten the BTD, they would have done a PR immediately.

3. Even if say they have added another 12 patients, this (in my estimation) would not be something to raise hopes a week in advance for.

4. Almost any other event or potential would come next Tuesday be a major letdown. The company could not get through that without major implications.

All these things considered, it doesn't seem prudent to wait til next Tuesday to buy. BUY NOW !!!

Those of us that have been here for the long ride need this upcoming great news. All longs have a great week.
Comment by Lesalpes29 on Jul 30, 2024 7:28am
Speculating and buying. Added 5k shares yesterday. Scratching my head right now! Do I buy more. GL
Comment by Gooseybear on Jul 30, 2024 1:24pm
It depends on how much you can afford the risk. Instead of buying a nice meal out, use the cash for more shares.
Comment by Galaxym31 on Jul 30, 2024 1:29pm
yes of course 125 dollars buys you 639 shares .
Comment by Oilminerdeluxe on Jul 30, 2024 7:32am
Point 1, I sound boring but I guess they will say they have gotten more or less all the info they needed and will soon apply for pre-BTD and shortly therafter BTD.. Although, I much prefer it your take on it :-) Anyway, it seems something is happening at least. Longest weekend to wait ever.
Comment by Gooseybear on Jul 30, 2024 10:30am
Nice bump in the stock on the US side. What time is the announcement?
Comment by riverrrow on Jul 30, 2024 9:14am
I'm inclined to believe Tuesday's news release will be another example of overpromise and under deliver.  GLTA.
Comment by Gooseybear on Jul 30, 2024 2:28pm
I'm still shaking my head at their headline on a recent PR that they cured cancer.
Comment by chry200030 on Jul 30, 2024 2:31pm
Unbelievable .... but true.... Coming to a clinic near you.... very soon...
Comment by DJDawg on Jul 30, 2024 10:20am
As much as I want to believe, I suspect it will be an announcement around a few more patients enrolled or a new research assistant hire or that they are now ready to submit for pre-BTD (but they will say in Q3-4 contingent on a few details....etc. )
Comment by managementfirst on Jul 30, 2024 9:28pm
All  good news are for following PR. Roger always like playing same trick.
Comment by managementfirst on Jul 30, 2024 9:29pm
PP, sorry
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250